Drug Trials Snapshots - LAZCLUZE
Summary
LAZCLUZE is a kinase inhibitor indicated in combination with amivantamab for the first-line treatment of adult patients with locally advanced or metastatic non-...
Description
LAZCLUZE is a kinase inhibitor indicated in combination with amivantamab for the first-line treatment of adult patients with locally advanced or metastatic non-...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source